PRF1 and breast carcinoma: Compared to healthy mammary glands, an increase in GzmC expression was noted in the PyMT model of breast cancer [21] and this suggests that part of the immune response to breast cancer may involve increased GzmC release by ILC1s eliciting cytotoxicity against tumour cells in a perforin dependent manner [87, 88].